triacetin has been researched along with n-acetylaspartic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ariyannur, PS; Arun, P; Grunberg, NE; Hamilton, K; Ives, JA; Moffett, JR; Namboodiri, AM; Xing, G | 1 |
| Davies, MT; Driscoll, HE; Jaworski, DM; Lawler, SE; Long, PM; Penar, PL; Pendlebury, WW; Spees, JL; Teasdale, BA; Tsen, AR; Viapiano, MS | 1 |
| Kurappalli, RK; Mekala, JR; Moparthi, NR; Ramalingam, P | 1 |
3 other study(ies) available for triacetin and n-acetylaspartic acid
| Article | Year |
|---|---|
Metabolic acetate therapy for the treatment of traumatic brain injury.
Topics: Acetates; Acetic Acid; Acetyl Coenzyme A; Animals; Aspartic Acid; Brain; Brain Injuries; Disease Models, Animal; Energy Metabolism; Lipid Metabolism; Male; Membrane Lipids; Myelin Sheath; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triacetin; Up-Regulation | 2010 |
Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.
Topics: Amidohydrolases; Animals; Antifungal Agents; Aspartic Acid; Astrocytes; Brain; Brain Neoplasms; Cell Cycle; Cells, Cultured; Dacarbazine; Dietary Supplements; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Neural Stem Cells; Temozolomide; Triacetin | 2014 |
N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in Glioblastoma cancer cells in vitro.
Topics: Apoptosis; Aspartic Acid; Brain Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; MicroRNAs; Triacetin; Tumor Cells, Cultured | 2021 |